Friedhelm Helling

1.7k total citations
18 papers, 1.4k citations indexed

About

Friedhelm Helling is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Friedhelm Helling has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Immunology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Friedhelm Helling's work include Glycosylation and Glycoproteins Research (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Immunotherapy and Immune Responses (9 papers). Friedhelm Helling is often cited by papers focused on Glycosylation and Glycoproteins Research (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Immunotherapy and Immune Responses (9 papers). Friedhelm Helling collaborates with scholars based in United States, Germany and Switzerland. Friedhelm Helling's co-authors include Philip O. Livingston, Sucharita Adluri, M J Calves, Shengle Zhang, Kenneth O. Lloyd, Gerd Ritter, Tao Yue, Gabriel Wong, Christine Hanlon and Dante J. Marciani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Friedhelm Helling

18 papers receiving 1.4k citations

Peers

Friedhelm Helling

IMMUN

RNMI

ONCOL

Sucharita Adluri United States

Ole Werdelin Denmark

Behjatolah Monzavi‐Karbassi United States

Ernesto Rodríguez Netherlands

Susanna M. Rybak United States

Andrea Woods United States

Katrien Princen Belgium

E L Barsumian Japan

Kathrine J. Smith United Kingdom

Justin M. Scheer United States

Sucharita Adluri United States

Friedhelm Helling

1.4k ×1.5

1.2k ×1.3

IMMUN

659 ×1.5

RNMI

526 ×1.4

ONCOL

537 ×2.0

Citations per year, relative to Friedhelm Helling Friedhelm Helling (= 1×) peers Sucharita Adluri

Countries citing papers authored by Friedhelm Helling

Since Specialization

Citations

This map shows the geographic impact of Friedhelm Helling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedhelm Helling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedhelm Helling more than expected).

Fields of papers citing papers by Friedhelm Helling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedhelm Helling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedhelm Helling. The network helps show where Friedhelm Helling may publish in the future.

Co-authorship network of co-authors of Friedhelm Helling

This figure shows the co-authorship network connecting the top 25 collaborators of Friedhelm Helling. A scholar is included among the top collaborators of Friedhelm Helling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedhelm Helling. Friedhelm Helling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Magagnoli, Claudia, et al.. (2009). Structural organization of NadAΔ351–405, a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level. Vaccine. 27(15). 2156–2170. 13 indexed citations

Livingston, Philip O., Shengle Zhang, Sucharita Adluri, et al.. (1997). Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies. Cancer Immunology Immunotherapy. 43(6). 324–330. 47 indexed citations

Zhang, Shengle, Friedhelm Helling, Govind Ragupathi, et al.. (1996). Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice.. PubMed. 56(14). 3315–9. 83 indexed citations

Zhang, Shengle, et al.. (1995). Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosides. Cancer Immunology Immunotherapy. 40(2). 88–94. 27 indexed citations

Adluri, Sucharita, Friedhelm Helling, Shunichiro Ogata, et al.. (1995). Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients. Cancer Immunology Immunotherapy. 41(3). 185–192. 2 indexed citations

Kitamura, K, P O Livingston, Sheila R. Fortunato, et al.. (1995). Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.. Proceedings of the National Academy of Sciences. 92(7). 2805–2809. 42 indexed citations

Helling, Friedhelm, Shengle Zhang, Sucharita Adluri, et al.. (1995). GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.. PubMed. 55(13). 2783–8. 171 indexed citations

Livingston, Philip O., Gabriel Wong, Sucharita Adluri, et al.. (1994). Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.. Journal of Clinical Oncology. 12(5). 1036–1044. 419 indexed citations

Helling, Friedhelm & Philip O. Livingston. (1994). Ganglioside conjugate vaccines. Molecular and Chemical Neuropathology. 21(2-3). 299–309. 19 indexed citations

10.

Livingston, Philip O., Sucharita Adluri, Friedhelm Helling, et al.. (1994). Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine. 12(14). 1275–1280. 181 indexed citations

11.

Helling, Friedhelm, M J Calves, Shengle Zhang, et al.. (1994). GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.. PubMed. 54(1). 197–203. 155 indexed citations

12.

Livingston, Philip O., M J Calves, Friedhelm Helling, et al.. (1993). GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3. Vaccine. 11(12). 1199–1204. 38 indexed citations

13.

Helling, Friedhelm, et al.. (1993). Construction of Immunogenic GD3‐Conjugate Vaccines. Annals of the New York Academy of Sciences. 690(1). 396–397. 4 indexed citations

14.

Helling, Friedhelm, et al.. (1993). Ganglioside expression on human malignant melanoma assessed by quantitative immune thin‐layer chromatography. International Journal of Cancer. 53(4). 566–573. 127 indexed citations

15.

Nores, Gustavo A., Roger D. Dennis, Friedhelm Helling, & Herbert Wiegandt. (1991). Human Heterophile Antibodies Recognizing Epitopes Present on Insect Glycolipids1. The Journal of Biochemistry. 110(1). 1–8. 19 indexed citations

16.

Helling, Friedhelm, Roger D. Dennis, Gustavo A. Nores, et al.. (1991). Glycosphingolipids in insects. European Journal of Biochemistry. 200(2). 409–421. 37 indexed citations

17.

Dennis, Roger D., Friedhelm Helling, Martin D. Keller, et al.. (1990). Glycosphingolipids in insects. European Journal of Biochemistry. 191(2). 379–388. 32 indexed citations

18.

Dąbrowski, Ursula, J. Da̧browski, Friedhelm Helling, & Herbert Wiegandt. (1990). Novel phosphorus-containing glycosphingolipids from the blowfly Calliphora vicina Meigen. Structural analysis by 1H and 1H[31P]-edited NMR spectroscopy at 600 and 500 megahertz.. Journal of Biological Chemistry. 265(17). 9737–9743. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact